| Role of TRIP13 in human cancer development. | Role of TRIP13 in human cancer development.
Chen C, Li P, Fan G, Yang E, Jing S, Shi Y, Gong Y, Zhang L, Wang Z. | 10/31/2024 |
| TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21. | TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21.
Zhang G, Yang R, Wang B, Yan Q, Zhao P, Zhang J, Su W, Yang L, Cui H., Free PMC Article | 08/28/2024 |
| TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells. | TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells.
Liu G, Wang H, Ran R, Wang Y, Li Y. | 07/31/2024 |
| High expression of TRIP13 is associated with tumor progression in H. pylori infection induced gastric cancer. | High expression of TRIP13 is associated with tumor progression in H. pylori infection induced gastric cancer.
Wu L, Xue Q, Xia X. | 05/24/2024 |
| Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma. | Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.
Afaq F, Agarwal S, Bajpai P, Diffalha SA, Kim HG, Peter S, Khushman M, Chauhan SC, Mukherjee P, Varambally S, Manne U., Free PMC Article | 02/1/2024 |
| Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma. | Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.
Xu L, Wang Y, Wang G, Guo S, Yu D, Feng Q, Hu K, Chen G, Li B, Xu Z, Jia X, Lu Y, Zhang H, Gao X, Chang S, Wang H, Wu X, Song D, Yang G, Zhu H, Zhou J, Zhan F, Zhu W, Shi J. | 07/7/2023 |
| Novel mutations in TRIP13 lead to female infertility with oocyte maturation arrest. | Novel mutations in TRIP13 lead to female infertility with oocyte maturation arrest.
Lv XJ, Guo J, Lin G. | 06/23/2023 |
| TRIP13 overexpression promotes gefitinib resistance in nonsmall cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway. | TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway.
Xiao Z, Li M, Zhang X, Rong X, Xu H., Free PMC Article | 03/14/2023 |
| MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells. | MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells.
Cao Y, Huang F, Liu J, Qi H, Xiao J. | 10/29/2022 |
| Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death. | Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death.
Rios Garcia M, Meissburger B, Chan J, de Guia RM, Mattijssen F, Roessler S, Birkenfeld AL, Raschzok N, Riols F, Tokarz J, Giroud M, Gil Lozano M, Hartleben G, Nawroth P, Haid M, López M, Herzig S, Berriel Diaz M., Free PMC Article | 10/22/2022 |
| Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers. | Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.
Ghosh S, Mazumdar T, Xu W, Powell RT, Stephan C, Shen L, Shah PA, Pickering CR, Myers JN, Wang J, Frederick MJ, Johnson FM., Free PMC Article | 10/22/2022 |
| TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis. | TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis.
Zhang LT, Ke LX, Wu XY, Tian HT, Deng HZ, Xu LY, Li EM, Long L., Free PMC Article | 06/11/2022 |
| Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways. | Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Lan J, Huang J, Tao X, Gao Y, Zhang L, Huang W, Luo J, Liu C, Deng Y, Liu L, Liu X., Free PMC Article | 05/14/2022 |
| TRIP13 knockdown inhibits the proliferation, migration, invasion, and promotes apoptosis by suppressing PI3K/AKT signaling pathway in U2OS cells. | TRIP13 knockdown inhibits the proliferation, migration, invasion, and promotes apoptosis by suppressing PI3K/AKT signaling pathway in U2OS cells.
Yu DC, Chen XY, Zhou HY, Yu DQ, Yu XL, Hu YC, Zhang RH, Zhang XB, Zhang K, Lin MQ, Gao XD, Guo TW. | 04/9/2022 |
| Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, IFNg, PIK3CA and CTNNB1 genes in different stage colorectal tumors | Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, IFNg, PIK3CA and CTNNB1 genes in different stage colorectal tumors.
Söylemez Z, Arıkan ES, Solak M, Arıkan Y, Tokyol Ç, Şeker H., Free PMC Article | 12/11/2021 |
| Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway. | Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.
Lu R, Zhou Q, Ju L, Chen L, Wang F, Shao J., Free PMC Article | 12/4/2021 |
| TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling. | TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling.
Cai W, Ni W, Jin Y, Li Y. | 10/23/2021 |
| [Regulation of TRIP13 on Proliferation and Apoptosis of B-Cell Lymphoma Cells and Its Mechanism]. | [Regulation of TRIP13 on Proliferation and Apoptosis of B-Cell Lymphoma Cells and Its Mechanism].
Yan SR, Zhang Q, Liu XC, Yuan JJ, Zhang F, Zhou KS. | 10/16/2021 |
| MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair. | MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair.
de Krijger I, Föhr B, Pérez SH, Vincendeau E, Serrat J, Thouin AM, Susvirkar V, Lescale C, Paniagua I, Hoekman L, Kaur S, Altelaar M, Deriano L, Faesen AC, Jacobs JJL., Free PMC Article | 10/16/2021 |
| TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status. | TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
Agarwal S, Behring M, Kim HG, Chandrashekar DS, Chakravarthi BVSK, Gupta N, Bajpai P, Elkholy A, Al Diffalha S, Datta PK, Heslin MJ, Varambally S, Manne U., Free PMC Article | 09/4/2021 |
| TRIP13 exerts a cancer-promoting role in cervical cancer by enhancing Wnt/beta-catenin signaling via ACTN4. | TRIP13 exerts a cancer-promoting role in cervical cancer by enhancing Wnt/β-catenin signaling via ACTN4.
Liu X, Shen X, Zhang J. | 09/4/2021 |
| TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial-mesenchymal transition. | TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial-mesenchymal transition.
Li ZH, Lei L, Fei LR, Huang WJ, Zheng YW, Yang MQ, Wang Z, Liu CC, Xu HT. | 08/14/2021 |
| Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth. | Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
Hu L, Shen D, Liang D, Shi J, Song C, Jiang K, Menglin Ren, Du S, Cheng W, Ma J, Li S, Bi X, Barr MP, Fang Z, Xu Q, Li W, Piao H, Meng S. | 03/28/2021 |
| p31(comet) promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase. | p31(comet) promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase.
Sarangi P, Clairmont CS, Galli LD, Moreau LA, D'Andrea AD., Free PMC Article | 12/19/2020 |
| Bi-allelic Missense Pathogenic Variants in TRIP13 Cause Female Infertility Characterized by Oocyte Maturation Arrest. | Bi-allelic Missense Pathogenic Variants in TRIP13 Cause Female Infertility Characterized by Oocyte Maturation Arrest.
Zhang Z, Li B, Fu J, Li R, Diao F, Li C, Chen B, Du J, Zhou Z, Mu J, Yan Z, Wu L, Liu S, Wang W, Zhao L, Dong J, He L, Liang X, Kuang Y, Sun X, Sang Q, Wang L., Free PMC Article | 10/24/2020 |